Urine free light chains as a novel biomarker of acute kidney allograft injury

Clinical Transplantation

Volumn 27, Issue 6, 2013, Pages 953-960

  Zhang, Rubin ^a   Li, Min ^a   Chouhan, Kanwaljit K ^a   Simon, Eric E ^a   Hamm, Lotuce Lee ^a   Batuman, Vecihil ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute rejection; Acute tubular necrosis; Biomarker; Kidney transplant; Urine free light chains

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BETA 2 MICROGLOBULIN; CYCLOSPORIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; KIDNEY INJURY MOLECULE 1; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREDNISONE; RAPAMYCIN; RETINOL BINDING PROTEIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY ALLOGRAFT INJURY; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MICROALBUMINURIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINARY EXCRETION;

ACUTE KIDNEY INJURY; ACUTE REJECTION; ACUTE TUBULAR NECROSIS; BIOMARKER; KIDNEY TRANSPLANT; URINE FREE LIGHT CHAINS;

ACUTE KIDNEY INJURY; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84889088476     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12271     Document Type: Article

References (38)

1. Nankivell BJ, Fenton-Lee CA, Kuypers DR et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001: 71: 515.
2. Nickerson P, Jeffery J, Gough J et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998: 9: 482.
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002: 346: 580.
4. Khan E, Batuman V, Lertora JJ. Emergence of biomarkers in nephropharmacology. Biomark Med 2010: 4: 805.
5. Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009: 24: 3263.
6. Huraib S, Goldberg H, Katz A et al. Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis 1989: 14: 13.
7. Beckingham IJ, Nicholson ML, Bell PR. Analysis of factors associated with complications following renal transplant needle core biopsy. Br J Urol 1994: 73: 13.
8. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008: 3: 481.
9. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002: 62: 237.
10. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004: 43: 405.
11. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005: 365: 1231.
12. Dieterle F, Perentes E, Cordier A et al. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 2010: 28: 463.
13. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008: 118: 1657.
14. Gaspari F, Cravedi P, Mandalà M et al. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract 2010: 115: c154.
15. Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury. Blood Purif 2010: 29: 357.
16. Valette JP, Nicot G, Charmes JP, Merle L, Benevent D, Leroux-Robert C. Low molecular weight proteins as urinary markers of aminoglycoside nephrotoxicity in man. Proc Eur Dial Transplant Assoc 1979: 16: 597.
17. Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR. Assessment of urinary retinol binding protein as an index of proximal tubular injury. Clin Chem 1987: 33: 775.
18. Batuman V, Verroust PJ et al. Myeloma light chains are ligands for cubilin (gp280). Am J Physiol 1998: 275: F246.
19. Klassen RB, Allen PL et al. Light chains are a ligand for megalin. J Appl Physiol 2005: 98: 257.
20. Batuman V. Proximal tubular injury in myeloma. Contrib Nephrol 2007: 153: 87.
21. Hutchison CA, Batuman V et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 2011: 8: 43.
22. Russo LM, Sandoval RM, McKee M et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 2007: 71: 504.
23. Waikar SS, Betensky RA, Emerson SC et al. Imperfect gold standards for kidney injury biomarker evaluation. Clin J Am Soc Nephrol 2012: 23: 13.
24. Khan E, Zhang R, Simon E, Hamm LL. Alloimmune injury in chronic allograft nephropathy. In: Monika G ed. Chronic Kidney Disease. Rijeka, Croatia: InTeck, 2012: 401, ISBN 978-953-51-0171-0.
25. Zhang R, Kumar P, Ramcharan T, Reisin E. Kidney transplantation: the evolving challenges. Am J Med Sci 2004: 328: 156.
26. Hollmen ME, Kyllönen LE, Inkinen KA, Lalla ML, Salmela KT. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011: 79: 89.
27. Kusaka M, Kuroyanagi Y, Mori T et al. Serum NGAL as a predictor of organ recovery form delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 2008: 17: 129.
28. Schröppel B, Krüger B, Walsh L et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 2010: 21: 536.
29. Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010: 21: 189.
30. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001: 344: 947.
31. O'Riordan E, Orlova TN, Mei JJ et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004: 15: 3240.
32. Renesto PG, Ponciano VC, Cenedeze MA et al. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 2007: 7: 1661.
33. Metzger J, Chatzikyrkou C, Broecker V et al. Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis. Proteomics Clin Appl 2011: 5: 322.
34. Heidt S, San Segundo D, Shankar S et al. Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011: 92: 1.
35. Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004: 4: 1475.
36. Cohan DJ, Vella JP. Transplantation: acute rejection. NephSAP 2011: 10: 561.
37. Bestard O, Cruzado JM, Franquesa ML, Grinyo JM. Biomarkers in renal transplantation. Curr Opin Organ Transplant 2010: 15: 467.
38. Suthanthiran M, Schwartz JE, Ding R et al. Urinary-cell mRNA and acute cellular rejection in kidney allografts. N Engl J Med 2013: 369: 20.